6550--hemochron signature elite reagents and supplies

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22, intends to solicit Hemochron Signature Elite reagents and supplies through a Sources Sought Notice with responses due by November 2, 2026 at 12:00 PM Pacific Time.

Performance will be at VA Southern Arizona Healthcare System, Tucson, Arizona. The acquisition covers a base period of two years (January 1, 2027 through December 31, 2028) plus four option years extending through December 31, 2032. Required supplies include Werfen-brand activated clotting time test cuvettes, Direct Check Abnormal and Normal ACT control solutions, and Hemochron JACT test supplies in specified quantities compatible with Hemochron Signature Elite instrumentation. All materials must be FDA-approved, maintain a minimum of 90 days remaining shelf life, and comply with current test methodologies without requiring workflow changes, retraining, or equipment modification.

Standard orders must be delivered within four working days during normal business hours (8:00 a.m. to 4:00 p.m. Arizona time), with 24/7 emergency delivery available at no additional cost unless expedited shipping is pre-approved. The contractor must provide 24/7 technical and product support at no additional cost and immediately notify the facility of backorders, supply interruptions, or recalls. Defective or out-of-range temperature materials must be replaced within 24 hours of notification.

Respondents should submit capabilities statements, business size status, manufacturer or authorized distributor confirmation, FDA clearance details, lead times, Buy American Act compliance documentation, SAM.gov registration, and tentative pricing for all five contract years to Rebecca Gaba at Rebecca.Gaba@va.gov. This procurement carries no set-aside.